Funding for this research was provided by:
Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico (305299/2018)
Research to Prevent Blindness (GR004596)
Received: 24 February 2022
Accepted: 5 August 2022
First Online: 17 August 2022
: The patient signed an informed consent before off label use of Melphalan IAC for Choroidal Melanoma was performed.
: None related to the discussed topic.